BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4129591)

  • 1. Dopa and 5-S-cysteinyldopa in the urine in healthy humans.
    Agrup G; Falck B; Kennedy BM; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1973; 53(6):453-4. PubMed ID: 4129591
    [No Abstract]   [Full Text] [Related]  

  • 2. Excretion of 5-S-cysteinyldopa in the urine of healthy subjects.
    Agrup G; Falck B; Fyge K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):7-9. PubMed ID: 46677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of 5-S-cysteinyldopa, dopa and dopamine in the urine by means of high-performance liquid chromatography. A comparison with data obtained by means of fluorometry.
    Morishima T; Saito M; Hanawa S
    J Dermatol; 1981 Aug; 8(4):301-4. PubMed ID: 6795251
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorometry of a DOPA peptide and its thioether.
    Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1971; 51(3):179-82. PubMed ID: 4103734
    [No Abstract]   [Full Text] [Related]  

  • 7. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM; Miller S; Gunder M
    Acta Derm Venereol; 1983; 63(2):97-101. PubMed ID: 6189350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-S-cysteinyldopa, dopa, and dopamine in the kidney and some other tissues.
    Agrup G; Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(1):63-4. PubMed ID: 6153836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
    Rorsman H; Rosengren AM; Rosengren E
    Yale J Biol Med; 1973 Dec; 46(5):516-22. PubMed ID: 4779132
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary 5-S-cysteinyldopa levels in patients with malignant melanoma. Preliminary results].
    Césarini JP; Meunier M
    Rev Prat; 1975 Nov; 25(51):4037-9. PubMed ID: 1209143
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Ito S; Kato T; Fujita K
    Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-(beta-carboxy-n-propyl)-L-cysteine and S-(beta-carboxyethyl)-L-cysteine in urine.
    Ohmori S; Shimomura T; Azumi T; Mizuhara S
    Biochem Z; 1965 Nov; 343(1):9-15. PubMed ID: 5874986
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo.
    Fujita K; Ito S; Inoue S; Yamamoto Y; Takeuchi J; Shamoto M; Nagatsu T
    Cancer Res; 1980 Jul; 40(7):2543-6. PubMed ID: 6771000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-OH-dopa, product of and substrate for tyrosinase.
    Agrup G; Rorsman H; Rosengren E
    Acta Derm Venereol; 1982; 62(5):371-76. PubMed ID: 6183884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursors of melanin in the blood and urine in malignant melanoma.
    Hinterberger H; Freedman A; Bartholomew RJ
    Clin Chim Acta; 1972 Jul; 39(2):395-400. PubMed ID: 5043774
    [No Abstract]   [Full Text] [Related]  

  • 19. Urine excretion of 5-S-cysteinyldopa and serum sialic acid as tumor markers in human melanomas.
    Marnot D; Decaux F; Berthelot P; Kalis B; Jardillier JC; Warren L
    Cancer Detect Prev; 1983; 6(1-2):303-10. PubMed ID: 6411338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sensitive method for determination of 5-S-cysteinyldopa.
    Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1973; 53(4):248-50. PubMed ID: 4127449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.